Additive effect of drospirenone/17-β-estradiol in hypertensive postmenopausal women receiving enalapril1
نویسندگان
چکیده
منابع مشابه
Percutaneous 17 beta-estradiol replacement therapy in hypertensive postmenopausal women.
The present study evaluated the short-term effects of percutaneous 17 beta-estradiol on blood pressure, metabolic profile and hormonal levels in postmenopausal women with systemic arterial hypertension. After a wash-out period of 15 days, 10 hypertensive patients were treated with guanabenz acetate to control blood pressure, followed by 17 beta-estradiol in the form of hydroalcoholic gel admini...
متن کاملHypertensive Disorders in Pregnant Women Receiving Fertility Treatments
Hypertensive disorders (HDs) as the most prevalent medical problem during pregnancy, predispose the patient to a lot of comorbidities and may even cause maternal or fetal death. The rate of infertility has been increasing in recent decades. So, we collected and summarized data about the co-existence of these two entities and found that HDs are somewhat more common in women receiving fertility t...
متن کاملThe Effect of Combined Training on Estradiol Levels and Metabolic Risk Factors in Overweight and Obese Postmenopausal Women
Objective: Menopause is a normal biological process associated with hormonal and metabolic changes. The purpose of this study was to investigate the effect of combined training on estradiol levels and some metabolic risk factors in obese and overweight postmenopausal women. Materials and Methods: In this quasi-experimental study, 24 postmenopausal women were randomly divided into experimental ...
متن کاملRandomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide.
OBJECTIVE Drospirenone (DRSP), a spironolactone analog with aldosterone antagonist activity, is a novel progestogen developed for use as hormone therapy in postmenopausal women in combination with 17beta-estradiol (E2). DRSP/E2 lowers blood pressure when used alone in hypertensive postmenopausal women or when administered concomitantly with angiotensin-converting enzyme inhibitors or angiotensi...
متن کاملOphthalmic artery vasodilation after intranasal estradiol use in postmenopausal women.
AIM The study aim was to evaluate the acute hemodynamic effects of intranasal 17-beta-estradiol on ophthalmic arterial circulation in postmenopausal women. METHODS Twenty-one healthy women in natural menopause for at least 6 months (mean age: 53.2± 2.9 years) were investigated. Each patient received 300 µg intranasal 17-beta-estradiol. We evaluated the heart rate, systolic and diastolic blood...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Hypertension
سال: 2002
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(02)02980-1